Period:
Draw Mode:
| Volume | 2,113 |
|
|||||
| News | - | ||||||
| Day High | 0.4973 | Low High |
|||||
| Day Low | 0.4525 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Titan Pharmaceuticals Inc | TTNP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0018 | -0.38% | 0.4719 | 15:24:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.492 | 0.4525 | 0.4973 | 0.4737 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 84 | 2,113 | $ 0.4678862 | $ 989 | - | 0.428 - 1.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:46:55 | 16 | $ 0.4561 | USD |
Titan Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.09M | 15.02M | - | 557k | -10.21M | -0.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Titan Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TTNP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4974 | 0.50 | 0.45 | 0.4700063 | 19,364 | -0.0255 | -5.13% |
| 1 Month | 0.52 | 0.524 | 0.45 | 0.4806796 | 21,635 | -0.0481 | -9.25% |
| 3 Months | 0.61 | 0.6984 | 0.428 | 0.5734435 | 93,140 | -0.1381 | -22.64% |
| 6 Months | 0.74 | 0.8451 | 0.428 | 0.6010179 | 52,657 | -0.2681 | -36.23% |
| 1 Year | 1.09 | 1.24 | 0.428 | 0.7219417 | 41,656 | -0.6181 | -56.71% |
| 3 Years | 5.16 | 8.85 | 0.3496 | 4.62 | 3,393,533 | -4.69 | -90.85% |
| 5 Years | 37.80 | 113.40 | 0.3496 | 13.74 | 4,718,872 | -37.33 | -98.75% |
Titan Pharmaceuticals Description
| Titan Pharmaceuticals Inc is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides efficacy and/or safety benefit. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate, or EVA, and a drug substance. Its first product based on ProNeura technology was the Probuphine (buprenorphine) implant, which was approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less a day of oral buprenorphine. |